Adage Capital Partners
AGN

Adage Capital Partners’s Allergan plc AGN Stock Holding History

Adage Capital Partners’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-9,369,802
Closed -$1.66B – 829
2020
Q1 		$1.66B Buy
9,369,802
+2,791,303
+42% +$526M 4.96% 1
2019
Q4 		$1.26B Buy
6,578,499
+206,800
+3% +$37.3M 3.09% 3
2019
Q3 		$1.07B Buy
6,371,699
+5,996,300
+1,597% +$977M 2.63% 4
2019
Q2 		$62.9M Buy
375,399
+50,930
+16% +$7.05M 0.16% 169
2019
Q1 		$47.5M Sell
324,469
-34,210
-10% -$4.96M 0.12% 205
2018
Q4 		$47.9M Sell
358,679
-440
-0.1% -$72.1K 0.13% 188
2018
Q3 		$68.4M Sell
359,119
-41,950
-10% -$7.71M 0.15% 167
2018
Q2 		$66.9M Sell
401,069
-20,800
-5% -$3.34M 0.15% 178
2018
Q1 		$71M Buy
421,869
+122,870
+41% +$20.6M 0.17% 161
2017
Q4 		$48.9M Sell
298,999
-116,524
-28% -$20.9M 0.11% 229
2017
Q3 		$85.2M Buy
415,523
+38,240
+10% +$8.89M 0.21% 136
2017
Q2 		$91.7M Buy
377,283
+26,450
+8% +$6.22M 0.22% 130
2017
Q1 		$83.8M Sell
350,833
-101,900
-23% -$23.7M 0.21% 136
2016
Q4 		$95.1M Sell
452,733
-422,060
-48% -$87.4M 0.26% 104
2016
Q3 		$201M Sell
874,793
-528,100
-38% -$129M 0.55% 36
2016
Q2 		$324M Buy
1,402,893
+156,959
+13% +$36.2M 0.88% 16
2016
Q1 		$334M Buy
1,245,934
+547,759
+78% +$157M 0.91% 11
2015
Q4 		$218M Buy
698,175
+128,800
+23% +$38.3M 0.57% 39
2015
Q3 		$155M Sell
569,375
-70,300
-11% -$21.6M 0.43% 58
2015
Q2 		$194M Hold
639,675
– – 0.48% 46
2015
Q1 		$190M Buy
639,675
+581,676
+1,003% +$166M 0.46% 45
2014
Q4 		$14.9M Sell
57,999
-324,660
-85% -$81.2M 0.04% 467
2014
Q3 		$92.3M Buy
382,659
+332,659
+665% +$74.4M 0.23% 118
2014
Q2 		$11.2M Buy
+50,000
New +$10.4M 0.03% 510
2014
Q1 		– Sell
-111,450
Closed -$18.7M – 751
2013
Q4 		$18.7M Sell
111,450
-74,200
-40% -$11.6M 0.05% 408
2013
Q3 		$26.7M Buy
185,650
+44,700
+32% +$5.95M 0.08% 307
2013
Q2 		$17.8M Buy
+140,950
New +$16M 0.05% 384

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Adage Capital Partners's AGN Position: Q2 2020 in Review

Adage Capital Partners sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 9,369,802 shares — an estimated $1.66B sold.

Adage Capital Partners first reported a position in AGN in Q2 2013 and held it in 27 quarters. The position peaked at $1.66B in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Adage Capital Partners reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Adage Capital Partners sold 9,369,802 Allergan plc shares in Q2 2020, an estimated $1.66B.
  • Adage Capital Partners first reported a position in Allergan plc in Q2 2013 and held it in 27 quarters.
  • Adage Capital Partners's Allergan plc position peaked at $1.66B in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.